IIP0943 is a selective inhibitor of PLK1 ( polo-like kinase 1), with an IC 50 of 5.1 nM for PLK1 . In addition, IIP0943 exhibits antiproliferative activity against HCT116 cells, with an IC 50 of 0.22 µM. These results suggest that IIP0943 holds promise for research in the field of cancer therapeutics.
Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Polo-like Kinase (PLK)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.